Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
2.240
-0.060 (-2.61%)
Nov 4, 2024, 4:00 PM EST - Market closed

Alpha Tau Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-27.63-29.16-33.76-27.27-8.88-8.37
Depreciation & Amortization
1.121.070.980.780.090.07
Stock-Based Compensation
9.017.936.750.810.60.55
Other Operating Activities
-4.81-0.292.4613.290.050.91
Change in Accounts Payable
0.221.140.220.240.110.15
Change in Other Net Operating Assets
1.251.35-0.530.350.79-0.21
Operating Cash Flow
-20.84-17.96-23.88-11.81-7.25-6.91
Capital Expenditures
-5.93-6.4-0.9-2.93-3.77-1.29
Investment in Securities
25.6528.24-89.0322.2-4.05-8.87
Other Investing Activities
-3.15-3.15----
Investing Cash Flow
16.5718.68-89.9419.27-7.82-10.16
Long-Term Debt Issued
-5.25----
Net Debt Issued (Repaid)
5.255.25----
Issuance of Common Stock
0.070.053.360.110.596.27
Other Financing Activities
--93.54---0.95
Financing Cash Flow
5.325.396.910.1129.325.32
Foreign Exchange Rate Adjustments
0.02-0.05-0.260.110.08-0.02
Net Cash Flow
1.075.97-17.177.6814.33-11.77
Free Cash Flow
-26.77-24.36-24.78-14.74-11.02-8.2
Free Cash Flow Per Share
-0.38-0.35-0.39-0.36-0.27-0.24
Cash Interest Paid
0.210.05----
Cash Income Tax Paid
0.010.020.0100-
Levered Free Cash Flow
-19.49-19.4-14.62-7.53-7.87-
Unlevered Free Cash Flow
-19.35-19.35-14.62-7.53-7.87-
Change in Net Working Capital
0.84-0.351.36-2.43-1-
Source: S&P Capital IQ. Standard template. Financial Sources.